Diet, nutrition, obesity and their role in arthritis by Sharkey, Peter F. et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Orthopaedic Surgery Faculty Papers Department of Orthopaedic Surgery
June 2007
Diet, nutrition, obesity and their role in arthritis
Peter F. Sharkey
Rothman Institute & Thomas Jefferson University, Peter.Sharkey@RothmanInstitute.com
David L. Paskin
Thomas Jefferson University
Thomas D. Meade
Allentown Orthopaedic Associates
Richard H. Rothman
Rothman Institute & Thomas Jefferson University
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/orthofp
Part of the Orthopedics Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Orthopaedic Surgery Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please
contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Sharkey, Peter F.; Paskin, David L.; Meade, Thomas D.; and Rothman, Richard H., "Diet, nutrition,
obesity and their role in arthritis" (2007). Department of Orthopaedic Surgery Faculty Papers. Paper 5.
http://jdc.jefferson.edu/orthofp/5
 ___________________________________________________________________________________________ 
This article has been peer reviewed.  It is the authors’ final version prior to publication in Seminars in Arthroplasty 
18(2):117-121, June 2007.  The published version is available at http://dx.doi.org/10.1053/j.sart.2007.03.009,  
copyright by Elsevier, Inc.   
1 
DIET, NUTRITION, OBESITY AND THEIR ROLE IN ARTHRITIS  
 
Peter F. Sharkey, MD.* 
David L. Paskin, MD.** 
Thomas D. Meade, MD.*** 
Richard H. Rothman, MD, PhD.* 
 
*     Rothman Institute, 925 Chestnut Street, Philadelphia, PA 19107 
**   Thomas Jefferson University Hospital, 111 South 11th Street, Philadelphia, PA 19107 
*** Allentown Orthopaedic Associates, 1243 S Cedar Crest Blvd, Allentown, PA 18103  
 
Key Words:  Obesity, nutrition, orthopaedic disease, dietary supplements.   
 
Abstract 
 
 Obesity and poor nutrition, individually and together, have created costly musculoskeletal 
disease epidemic in the United States.  Processed food, with abundant “empty” calories, has 
contributed greatly to our dietary woes.  Much of the food consumed today is packed with 
calories but refined to the point that essential nutrients are lacking. Even worse, processed food 
may have ingredients added that are detrimental to good health.  Abundant research has 
documented a close relationship between obesity, poor diet and orthopaedic problems.  Dietary 
supplements have been proven to provide both disease prevention and therapeutic benefits.  
Unfortunately, many weight loss programs and methods are ineffective and possibly dangerous.  
Additionally, the FDA does not regulate the nutritional supplement industry and product quality 
is high variable.  It is imperative that physicians treating patients with musculoskeletal 
complaints understand these disease producing relationships and have a network in place to refer 
patients to reputable weight loss entities and for high quality nutritional supplements.   
 
Background 
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Until a few generations ago, almost all of the food we consumed was harvested from the 
ground, picked from a tree or hunted, killed, and eaten after little processing.  Processed food did 
not exist or was very scarce. Anyone who consumed enough food from diverse sources was 
adequately nourished both in terms of calories and essential nutrients. Today highly refined food 
packed with calories and taste is the primary staple for many Americans and for the first time in 
man’s history, malnourished and overweight is a common problem. Delicious calorie rich “fast 
food” has led to an obesity epidemic in America.  What’s worse is that much of the processed 
food we eat lacks essential nutrients necessary for good health. Our dietary woes are common 
knowledge and were documented recently in the satirical film “Super Size Me”.  For those who 
have not viewed this movie, the significant weight gain demonstrated with a one month diet 
composed exclusively of fast food is appalling.  However, more concerning is the tremendous 
negative health impact that this type of diet causes.  In addition to vitamins, a processed diet may 
lack minerals, essential fatty acids, antioxidants and fiber, all of which we need for good health.  
The deleterious effects of obesity and poor diet extend well beyond the cardiovascular system.  
Recent research has shown that obesity and poor diet also causes musculoskeletal disease.1, 2, 
3,4,5,6
 This article will review the relationship between these entities and evaluate ways that the 
physician can improve orthopaedic health or prevent disease through diet.   
 
Obesity and Degenerative Joint Disease  
 
The American obesity epidemic has led to a substantial increase in a plethora of diseases 
including diabetes, hypertension and cardiovascular pathology.  Obesity related disease is 
estimated to account for an amazing 6.8% of all U.S. healthcare costs and with regards to the 
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musculoskeletal system a close association between obesity and degenerative joint disease has 
been documented. ,3,5,6    In one study of patients undergoing total hip or total knee arthroplasty, 
it was demonstrated that an increased body mass index (BMI) was closely associated with the 
need for joint replacement.  Patients with a BMI between 37.5 and 40.0 have an odds ratio for 
needing a joint replacement of 9.4 compared with non-obese controls. 5    In the so-called 
“Nurses Health Study”, women with a BMI > 35 were twice as likely to develop hip or knee 
osteoarthritis compared with subjects having a normal body weight. 6   Women with an elevated 
BMI by 18 years of age were five times more likely to develop osteoarthritis.  It has been 
estimated that obesity is directly or indirectly responsible for over 200,000 joint replacements in 
the United States annually. 7    How obesity causes arthritic disease is an obviously important 
question. The common and anecdotal explanation is that excessive joint loading leads to cartilage 
deterioration and eventually symptomatic arthritis.  This joint overload theory simplifies the 
pathophysiology of degenerative joint disease. To exemplify this point, consider a 170 pound 
long distance runner.  During a run, the force on the knee for this individual approximates 2.0 
Newtons per millimeter2.  Conversely, at heel strike, a 250 pound individual, when walking, 
generates a knee joint force of approximately 2.0 Newtons per millimeter2  .  A long distance 
athlete may run upwards of 30 miles per week.  Meanwhile an obese person is often sedentary.  
If excessive joint loading was the correct theory of osteoarthritis, there would be an epidemic of 
arthritic disease in runners and the obese would be sparred. In fact, clinical studies reflect just the 
opposite with evidence showing that running probably does not contribute and my even lower 
the risk of degenerative joint disease. 8     If it was just a mechanical issue, why are heavy 
patients prone to arthritis but less likely to have polyethylene wear after total joint replacement.9   
The most likely answer is that obesity related arthritis is caused by systemic inflammation. 
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Obesity and poor nutrition activate the immune system and cause a low grade state of systemic 
inflammation.  Intra-abdominal adipose tissue is metabolically active and generates 
inflammatory mediators. 10    Excess adipose tissue is associated with insulin resistance, 
hypertension, dyslipidemia, and prothrombosis. However, very importantly, it is also associated 
with a pro-inflammatory status. 10  Support for this theory of obesity associated arthritis is 
abundant.  Anedotally, it has been observed that obesity is associated with not only a higher 
incidence of lower extremity arthritis, but also more degenerative disease of upper extremity 
joints. 11  Of course, these joints are non-weightbearing and a mechanical explanation for upper 
extremity arthritis is not rational. This finding suggests a systemic explanation for obesity related 
arthritis.  A recent study demonstrated that obesity is associated with elevated levels of c-reactive 
protein and increased erythrocyte sedimentation rates, both markers for inflammation. 12  In 
addition, obese individuals have significantly higher levels of pro-inflammatory mediators 
including, interleukin-6 and tumor necrosis factor alpha. 12   The elevation of inflammatory 
markers and mediators is more profound in woman than men and this may explain the epidemic 
of arthritis amongst obese women. 13    In addition, individuals with an “apple shaped” (more 
intraabdominal adipose tissue) build have been shown to be much more likely to suffer from 
systemic inflammation than “pear shaped” morphotypes. 13        The basic science of the 
relationship between adipose tissue and inflammation has also been investigated. Adipocytes 
secrete adipocytokines which mediate inflammation.  10     Obese individuals have been found to 
have higher levels of adipocytokines in synovial fluid .14     Adipocytes contain large quantities 
of arachidonic acid which is the building block for pro-inflammatory eicosanoids including 
prostaglandins, thromboxanes and leukotrienes. 14     Investigators have suggested that there is a 
“role of adipose tissue in arthritis”. 10       The knee is a fat sequestering joint and large quantities 
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of adipose tissue in the knee joint may explain the projected enormous rise in the number of total 
knee arthroplasties predicted for the next two decades.  
 
The Role of Nutrition in Arthritis 
 
Obesity alone does not completely explain the link between dietary habit and arthritis.  
While almost no one in the United States is starving for calories, the refined and artificial diet 
that many Americans consume, creates deficiencies of essential nutrients needed for optimal 
musculoskeletal health.  Vitamins, trace minerals, essential fatty acids and antioxidants along 
with other substances can only be obtained in adequate quantities from a high quality diet or by 
consuming nutritional supplements.  These agents are needed for good orthopaedic health and 
deficiencies lead to significant clinical sequelae.  Unfortunately, high caloric, nutrient depleted, 
processed and flavored food is generally less expensive and tastes better than healthy fresh food.  
Healthy fresh food often requires expensive methods of preservation.  Cost, taste, and lack of 
knowledge drives many Americans to eat low quality food which promotes less than optimal 
health. The problem is so ubiquitous and profound that in a country with abundant resources for 
producing food, nutritional deficiencies are common. All substances needed for good 
musculoskeletal health cannot be fully evaluated in this short manuscript but the role of key 
ingredients for a healthy orthopaedic diet can be described.   
 
Dietary Supplements 
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In a perfect world, we would all consume a diet providing everything needed for optimal 
health.  Unfortunately, even educated, conscientious consumers frequently stray from ideal 
dietary habits. The difficulty of “eating right” all the time partially explains the exponential rise 
in sales for the dietary supplement industry.  It seems ironic that many of us travel to our local 
supermarket to purchase nutrient depleted food and then on the way home, stop at a dietary 
supplement shop to purchase ingredients we believe are missing from our diet.  The Foundation 
of Innovative Medicine has reported that 74% of surveyed consumers purchase dietary 
supplements. 15   However, 68% of supplement users are not confident that they are taking the 
correct products or using them properly. Many patients look to their physicians for advice on 
supplements, but may be uncomfortable asking about what they consider to be a deviation from 
mainstream medicine. The typical American diet today has deficiencies of vitamins, trace 
minerals, essential fatty acids, fiber, and antioxidants.  The optimal diet should consist of the 
proper amounts of protein, carbohydrates, and fats. Studies have shown that ideally we should 
consume seven servings of fruits and vegetables daily. 16 To get enough omega-3 essential fatty 
acids, we need to eat four to five servings of fish per week. 17  Many of us lack the time, desire, 
energy, financial means, and knowledge to follow this sort of dietary regimen.  Dietary 
supplements are meant to correct the “unbalanced”, low nutritional value, high caloric diet.  Use 
of dietary supplements is not the best option, eating correctly is.  However, from a practical 
perspective, use of supplements is the second best method to ensure adequate intake of 
everything needed for optimal health.  There is abundant evidence that dietary supplements can 
treat or prevent disease.  
 
Vitamin D and Calcium 
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The role of vitamin D and calcium in phosphate absorption and bone formation is well 
known to orthopaedic surgeons.  Deficiencies lead to rickets in childhood and adult 
osteomalacia. 18,19  The recommended daily dosage of vitamin D is 400 International Units (IU). 
However, because of the osteoporosis epidemic, the FDA has contemplated increasing this 
requirement to 1,000 IU. 20       Osteoporosis related fractures cause an enormous strain on our 
healthcare system both financially and measured by human suffering.  Calcium deficiency 
coupled with inadequate vitamin D exponentially promotes the development of osteoporosis 
associated with aging. 21 The current recommendations for calcium and vitamin D intake are 
frequently not satisfied by many and osteoporosis is rampant.  19, 22, 23, 24      
 
In addition, vitamin D seems to have a beneficial effect on osteoarthritis minimallizing 
the symptoms associated with this disease. The Framingham Study which has carefully 
documented, over many decades, the relationship between lifestyle, diet and health revealed that 
individuals who consume large amounts of vitamin D are three times less likely to develop 
symptomatic arthritis. 25 While consumption of vitamin D did not effect the incidence of 
osteoarthritis, it did decrease the frequency of symptoms associated with this disease.  Increases 
in bone stress associated with cartilage loss can cause pain and loss of cartilage resulting in 
deformity which significantly increases forces on the effected bone.  This increase in stress leads 
to microfracture and painful inflammation. This phenomenon has been described by findings on 
MRI which are categorized as bone marrow lesions. 26  These bone marrow lesions equate to 
stress or insufficiency fractures of bone.  Enhanced bone strength associated with vitamin D 
consumption may explain its positive role in this disease process.  In the Framingham Study, 
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individuals who consumed the most vitamin D (“highest tertile”) were more than three times less 
likely to have symptomatic arthritis compared with those in the lowest consumption tertile.  In 
addition, high levels of vitamin D are associated with a slower progression of radiographic 
deformity.  This finding is likely explained by higher quality bone resisting deformity and 
erosion.   
 
 
 
 
 
 
 
Glucosamine and Chondroitin Sulfate  
 
Healthy chondrocytes manufacture glucosamine and in these same cells through a series 
of steps convert glucosamine to chondroitin sulfate, a glucosamineoglycan (GAG).  GAG’s are 
an essential component of the cartilage matrix and determine the durability and mechanical 
properties of the cartilage matrix. 27  Aging chondrocytes produce less glucosamine and 
deficiency of this substance is believed to lead to cartilage deterioration. 27 This relative 
deficiency of glucosamine may explain the relationship between arthritis and aging and the 
beneficial role of this agent for preventing age related degenerative joint disease.  Commercially, 
chondroitin sulfate is frequently combined with glucosamine.  Individually, chondroitin sulfate 
has been shown to stimulate GAG production and inhibit pro-inflammatory activity. 28  It is has 
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been demonstrated that chondroitin sulfate and glucosamine have synergetic characteristics and 
anabolic effects are greater when these agents are combined. 29  Chondroitin sulfate and 
glucosamine have been shown to work as well or better than non-steroidal anti-inflammatory 
drugs for treatment of arthritic symptoms in several well controlled studies. 30,31,32,33,34,35,36  In a 
recent blinded, controlled NIH funded study of glucosamine and chondroitin sulfate this 
combination was found to be more effective than Celebrex for moderate to severe arthritic 
symptoms. 37 
Essential Fatty Acids 
 
Fatty acids (examples are Omega 3 and Omega 6) are “essential” dietary constituents and 
cannot be endogenously produced. Their role in physiologic homeostasis is extensive, but 
pertinent to this article, they serve as important inflammation mediators. 16   
 Fatty acids are the precursors of prostaglandins, thromboxanes and leukotrienes.  Omega 
6 fatty acids function as the building blocks for proinflammatory agents while omega 3 fatty 
acids generate inflammation suppressing mediators. Evidence exists that for optimal, healthy 
regulation of the immune system, omega 3 and omega 6 fatty acids should be consumed in 
approximately a 1:1 ratio. 16  Excessive intake of omega 6 fatty acids creates a proinflammatory 
state which leads to inflammatory related disease. 37  Unfortunately, omega 6 fatty acids are 
ubiquitous in the modern American diet.  Omega 6 fatty acids are found in vegetable oils and 
these agents are frequently added to processed foods to enhance their appearance and taste.  
Supplemental use of omega 3 fatty acids has been shown to have therapeutic effects for many 
chronic inflammatory conditions including asthma, eczema, psoriasis, lupus and ulcerative 
colitis. 38  
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 There are numerous studies demonstrating that omega 3 supplements produce beneficial 
effects on the symptoms of rheumatoid arthritis. 39,40,41,42,43,44,45,46,47,48,49  In one double blind, 
placebo controlled study patients with rheumatoid arthritis who consumed 1.8 grams of EPA (a 
type of omega 3 fatty acid) per day had less morning stiffness and joint tenderness. 41 Continuous 
use of this supplement provides extended relief of inflammatory arthritic symptoms.  In a recent 
study, patients with rheumatoid arthritis taking 2.6 grams of omega 3 fatty acids per day 
continuously for one year reported significant clinical benefits and reductions in the need for 
drug therapy. 49  The efficacy of omega 3 fatty acids for the treatment of osteoarthritic symptoms 
has not been evaluated but the inflammatory component of this disease suggests potential benefit 
could be obtained using Omega 3 supplements.  
 
Antioxidants  
 
 Reactive oxygen and nitrogen species (free radicals) have been shown to play a 
significant role in the parthenogenesis of inflammatory arthritis. 50 These highly reactive 
molecules can bind to substances in the cartilage collagen matrix disrupting the normal 
homeostasis of this network.  Eventually deterioration of collagen occurs and osteoarthritis 
follows.  Nitric oxide synthase is a key enzyme evolved in the formation of free radicals.  
Aspirin, tetracycline, steroids, and methotrexate have been shown to suppress nitric oxide 
synthesis and this may partially explain their anti-inflammatory properties. 50  
 Dietary antioxidants can neutralize free radicals before they inflict tissue damage.  
Numerous studies have shown a beneficial effect when patients with arthritis consume adequate 
doses of antioxidants. 51,52,53 Vitamins A, C, E , and selenium have significant capacity to 
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consume free radicals.  Several studies have shown that vitamin E supplements are effective for 
the treatment of arthritis symptoms. 51,52,53 Combining vitamins C and E has revealed a 
synergistic effect between these agents for treating arthritis. The Framingham Arthritis Study 
demonstrated antioxidant supplements had a preventive effect on arthritis progression. 25 Based 
on radiographic parameters, there was a 3 fold reduction in arthritis disease progression for 
patients consuming the highest amount of vitamin C.  Those same patients were much less likely 
to develop symptomatic osteoarthritis.   
 
What Can Orthopaedic Surgeons Do? 
 
Obviously the practice of good medicine is more than surgically replacing worn out 
joints.  All orthopaedic surgeons should practice mindful of disease prevention and non-
operative options.  Overweight patients should be educated about the close relationship between 
orthopaedic disease and obesity.  The physician should be knowledgeable about treatment 
options for obesity and be aware of the best sources for referral.  Bariatric surgery has evolved as 
quickly as the obesity epidemic has grown and is safer and more effective than in the past.  
Morbidly obese patients should be appropriately referred to centers with the lowest complication 
rates and least invasive methods.   For patients who are moderately overweight, weight loss 
centers are available and often effective.  As we all know, entities promoting assistance with 
weight loss are not all reputable and safe.  It is imperative that the physician be aware of the best 
weight loss resources and programs available in the area where they practice. A medically 
supervised weight loss program is in the patient’s best interest.  Larger groups practicing high 
volume joint replacement should consider employing a registered dietician developing an “in- 
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house” medically supervised weight loss program that provides patients with enhanced care.  In 
addition, this program can serve as a source of ancillary income.  Patients often ask their doctors 
advice about dietary supplements. This is a rapidly growing industry with a plethora of available 
products. The evidence of clinical efficacy for each individual product is highly variable.  
Additionally, because the FDA does not closely regulate this industry, the quality of a specific 
product is very dependent on the manufacturer.  It is important for physicians to be aware of the 
pertinent scientific evidence supporting a particular product.  In addition, a well educated doctor 
knows about supplement quality and can assist his or her patient in making appropriate choices 
for selecting these products.  Appropriate, high quality, nutritional supplements may be used to 
treat or prevent musculoskeletal disease in many patients. Considering that approximately 17,000 
fatal complications related to non-steroidal anti-inflammatory medications occur annually, it 
seems prudent to consider alternative treatment options.   
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